Following Denmark, Norway also suspends use of AstraZeneca coronavirus vaccine
Denmark had temporarily halted the use of the manufacturer's vaccine over fears of a link to blood clots
March 11, 2021
- Norway has decided to temporarily stop the use of AstraZeneca's COVID-19 vaccine as a precautionary measure.
- Earlier in the day, Denmark had also temporarily halted the use of the manufacturer's vaccine over fears of a link to blood clots.
- Norway's National Institute of Health says it is waiting for more data to see if blood clots are linked to use of the vaccine.
OSLO: Health authorities in Norway on Thursday decided to temporarily suspend the use of AstraZeneca's COVID-19 vaccine as a precaution following Denmark's decision to do so over fears of a link to blood clots.
"We are pausing the AstraZeneca vaccination in Norway," the director of infection prevention and control at the National Institute of Health, Geir Bukholm, told reporters.
"We are waiting for more information to see if there is a link between the vaccine and this blood clot case," he said.
Earlier in the day, Denmark announced that it was temporarily halting the use of the AstraZeneca COVID-19 vaccine after several cases of blood clots among vaccinated people, the Danish health authority said on Thursday.
